Literature DB >> 14354794

[Experimental studies on the mechanism of infection and immunity in tuberculosis from the analytical standpoint of streptomycin-dependent tubercle bacilli. 1. Isolation and biological characteristics of a streptomycin-dependent mutant, and effect of streptomycin administration on its pathogenicity in guinea-pigs].

T HASHIMOTO.   

Abstract

Entities:  

Keywords:  MYCOBACTERIUM TUBERCULOSIS; STREPTOMYCIN/effects

Mesh：

Substances：

Year:  1955        PMID： 14354794

Source DB:  PubMed          Journal:  Kekkaku        ISSN： 0022-9776


× No keyword cloud information.
  10 in total

1.  Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis.

Authors:  Claudia Sala; Neeraj Dhar; Ruben C Hartkoorn; Ming Zhang; Young Hwan Ha; Patricia Schneider; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

2.  Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro.

Authors:  E D Pieterman; M J Sarink; C Sala; S T Cole; J E M de Steenwinkel; H I Bax
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

3.  Streptomycin-dependent exhibition of cytokine-inducing activity in streptomycin-dependent Mycobacterium tuberculosis strain 18b.

Authors:  Yutaka Fukasawa; Ikuo Kawamura; Ryosuke Uchiyama; Kazuhiro Yamamoto; Taijin Kaku; Takanari Tominaga; Takamasa Nomura; Satoshi Ichiyama; Takayuki Ezaki; Masao Mitsuyama
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  Modelling a Silent Epidemic: A Review of the In Vitro Models of Latent Tuberculosis.

Authors:  Savannah E R Gibson; James Harrison; Jonathan A G Cox
Journal:  Pathogens       Date:  2018-11-15

5.  Unique model of dormant infection for tuberculosis vaccine development.

Authors:  Suely S Kashino; Pamela Ovendale; Angelo Izzo; Antonio Campos-Neto
Journal:  Clin Vaccine Immunol       Date:  2006-09

6.  Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.

Authors:  Ming Zhang; Claudia Sala; Ruben C Hartkoorn; Neeraj Dhar; Alfonso Mendoza-Losana; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

Review 7.  Current and novel approaches to vaccine development against tuberculosis.

Authors:  Mark J Cayabyab; Lilia Macovei; Antonio Campos-Neto
Journal:  Front Cell Infect Microbiol       Date:  2012-12-06       Impact factor: 5.293

Review 8.  Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds.

Authors:  André Campaniço; Shrika G Harjivan; Digby F Warner; Rui Moreira; Francisca Lopes
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

9.  Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b.

Authors:  Andrej Benjak; Swapna Uplekar; Ming Zhang; Jérémie Piton; Stewart T Cole; Claudia Sala
Journal:  BMC Genomics       Date:  2016-03-05       Impact factor: 3.969

Review 10.  Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review).

Authors:  Anna Egorova; Elena G Salina; Vadim Makarov
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.